1. RNAi silencing of P/Q-type calcium channels in Purkinje neurons of adult mouse leads to episodic ataxia type 2
- Author
-
Julie Salvi, Fabrice Ango, Céline Lemmers, Federica Bertaso, Laurent Fagni, Alexandra Metz, Anne-Laure Mausset-Bonnefont, Philippe Lory, Alexandre Mezghrani, Institut de Génomique Fonctionnelle (IGF), Université de Montpellier (UM)-Université Montpellier 1 (UM1)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Montpellier 2 - Sciences et Techniques (UM2)-Centre National de la Recherche Scientifique (CNRS), Institut des Neurosciences de Montpellier - Déficits sensoriels et moteurs (INM), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Institut de Biologie du Développement de Marseille (IBDM), Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), Université Montpellier 1 (UM1)-Université Montpellier 2 - Sciences et Techniques (UM2)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), and Institut des Neurosciences de Montpellier (INM)
- Subjects
Male ,Cerebellum ,Mouse ,[SDV]Life Sciences [q-bio] ,Inbred C57BL ,Transgenic ,Membrane Potentials ,Purkinje Cells ,Nystagmus ,Mice ,0302 clinical medicine ,Calcium Channels, N-Type ,RNA interference ,Transduction, Genetic ,Carbonic anhydrase inhibitor ,RNA, Small Interfering ,Postural Balance ,ComputingMilieux_MISCELLANEOUS ,0303 health sciences ,P/Q-type calcium channel ,Voltage-dependent calcium channel ,Purkinje neuron ,3. Good health ,Small Interfering/genetics/*physiology ,Purkinje Cells/*metabolism ,medicine.anatomical_structure ,Neurology ,RNA Interference/*physiology ,N-Type/genetics/*metabolism ,Postural Balance/genetics ,medicine.symptom ,Acetazolamide ,medicine.drug ,medicine.medical_specialty ,Ataxia ,medicine.drug_class ,Movement ,Green Fluorescent Proteins ,Membrane Potentials/drug effects/genetics ,Mice, Transgenic ,Biology ,Nystagmus, Pathologic ,lcsh:RC321-571 ,03 medical and health sciences ,Transduction ,Cerebellum/metabolism/*pathology ,Genetic ,Internal medicine ,Green Fluorescent Proteins/genetics/metabolism ,medicine ,Gene silencing ,Animals ,Humans ,lcsh:Neurosciences. Biological psychiatry. Neuropsychiatry ,030304 developmental biology ,Episodic ataxia ,Animal ,medicine.disease ,Mice, Inbred C57BL ,Disease Models, Animal ,Ataxia/*etiology/genetics/pathology/physiopathology ,Endocrinology ,HEK293 Cells ,Disease Models ,Movement/physiology ,RNA ,Calcium Channels ,Pathologic/*etiology/genetics/pathology/physiopathology ,Neuroscience ,030217 neurology & neurosurgery - Abstract
Episodic ataxia type-2 (EA2) is a dominantly inherited human neurological disorder caused by loss of function mutations in the CACNA1A gene, which encodes the CaV2.1 subunit of P/Q-type voltage-gated calcium channels. It remains however unknown whether the deficit of cerebellar CaV2.1 in adult is in direct link with the disease. To address this issue, we have used lentiviral based-vector RNA interference (RNAi) to knock-down CaV2.1 expression in the cerebellum of adult mice. We show that suppression of the P/Q-type channels in Purkinje neurons induced motor abnormalities, such as imbalance and ataxic gait. Interestingly, moderate channel suppression caused no basal ataxia, while β-adrenergic activation and exercise mimicked stress induced motor disorders. Moreover, stress-induced ataxia was stable, non-progressive and totally abolished by acetazolamide, a carbonic anhydrase inhibitor used to treat EA2. Altogether, these data reveal that P/Q-type channel suppression in adult mice supports the episodic status of EA2 disease.
- Published
- 2014
- Full Text
- View/download PDF